Crystallographic studies of equilibrative nucleoside transporters
Crystallographic studies of equilibrative nucleoside transporters
批准号:
7762743
负责人:
Olga Boudker
金额:
$17.58万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-02-01 至 2011-01-31
关键词:
AchievementAdenosineAdoptedAffinityAmino AcidsAntiparasitic AgentsAntiviral AgentsBindingBiologicalBlood PlateletsBody TemperatureBrainCell membraneCellular MembraneCrystallizationDetergentsDipyridamoleEpilepsyExhibitsFamilyFamily memberFunctional disorderGoalsHomologous GeneHumanImmunosuppressive AgentsIntegral Membrane ProteinLigand BindingLigandsLipid BilayersLipidsLocationMaintenanceMediatingMedicalMembrane ProteinsMembrane Transport ProteinsMolecularMolecular ConformationMutagenesisMutateMutationNatureNucleoside TransporterPainParkinson DiseasePerceptionPharmaceutical PreparationsPhysiologicalPhysiologyPredispositionPreventionProcessProductionProtein DynamicsProtein EngineeringProteinsProtocols documentationRouteSeizuresSignal TransductionSignaling MoleculeSleepSolutionsStrokeStructureSupplementationSynapsesThrombusTransmembrane DomainVariantVasodilationYeastsbaseextracellularinhibitor/antagonistloss of functionmilligrammutantneurological pathologynucleoside analogpreventpublic health relevanceresearch studyreuptakestructural biologysuccessthree dimensional structureuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Equilibrative nucleoside transporters (ENTs) are the predominant membrane transporters in humans mediating the uptake and efflux of adenosine, which is an important inter-cellular signaling molecule mediating a wide range of effects from neuro- and cardioprotection to pain perception, susceptibility to seizures and sleep cycle. Despite their immense significance in human physiology and pathophysiology, little is known about the mechanism by which ENTs recognize and translocate their substrates across hydrophobic lipid bilayers. In this proposal we focus on the crystallization of ENT homologues, a critical step towards determining the crystal structure of these molecules. We have already identified ENT homologues with superb structural stability in detergent and established expression and purification protocols for them that routinely yield milligram quantities of stable homogeneous proteins. We will further optimize the protein constructs, detergents, ligands and lipid supplementation to achieve transporters crystallization. An important concern is that membrane transporters are dynamic proteins by nature, and that in solution they may distribute over multiple state hindering crystallization. To circumvent this problem, we will systematically mutate 27 highly conserved amino acids within hENT1, which is one of the crystallization candidates, and implement a functional screen in yeast in order to identify the loss-of-function mutants, that are highly expressed, stable in detergent and capable of tight substrate binding but not transport. We hypothesize that such mutants will be deficient in transport because they are unable to undergo some or all of the essential conformation transitions and are, thus conformationally constrained. We will evaluate whether such mutants would provide distinct benefits in the crystallization process. The success of this project will have a major impact on the studies of ENTs and possibly on the larger field of the structural biology of dynamic membrane proteins such as channels and transporters. PUBLIC HEALTH RELEVANCE: Adenosine is an important signaling molecule in humans, regulating a wide range of effects such as vasodilatation, thrombus formation, pain perception, sleep cycle, and body temperature. Specialized proteins in the cellular membranes, equilibrative nucleoside transporters control the levels of adenosine available for signaling. They are the targets of many drugs such as dipyridamole, which is widely used to prevent secondary strokes. Here we propose to crystallize these molecules, an essential step toward determination of their atomic structure, which in itself is essential to understand the transporters mechanism and to increase our capacity to pharmacologically control their function.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Biophysics Training Program
-
批准号:10631072
-
项目类别:
-
资助金额:$21.22万
-
财政年份:2020
-
负责人:Olga Boudker
-
依托单位:
Molecular Biophysics Training Program
-
批准号:10174963
-
项目类别:
-
资助金额:$19.51万
-
财政年份:2020
-
负责人:Olga Boudker
-
依托单位:
Molecular Biophysics Training Program
-
批准号:10413109
-
项目类别:
-
资助金额:$20.81万
-
财政年份:2020
-
负责人:Olga Boudker
-
依托单位:
Mechanisms of Membrane Transport GRC 2019
-
批准号:9761723
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2019
-
负责人:Olga Boudker
-
依托单位:
The mechanism of allosteric modulation of glutamate transporters
-
批准号:10303051
-
项目类别:
-
资助金额:$56.75万
-
财政年份:2019
-
负责人:Olga Boudker
-
依托单位:
The mechanism of allosteric modulation of glutamate transporters
-
批准号:9916361
-
项目类别:
-
资助金额:$60.26万
-
财政年份:2019
-
负责人:Olga Boudker
-
依托单位:
The mechanism of allosteric modulation of glutamate transporters
-
批准号:10532749
-
项目类别:
-
资助金额:$57.19万
-
财政年份:2019
-
负责人:Olga Boudker
-
依托单位:
The mechanism of allosteric modulation of glutamate transporters
-
批准号:10059284
-
项目类别:
-
资助金额:$57.88万
-
财政年份:2019
-
负责人:Olga Boudker
-
依托单位:
The structural dynamics of a glutamate transporter homologue
-
批准号:9093868
-
项目类别:
-
资助金额:$59.4万
-
财政年份:2014
-
负责人:Olga Boudker
-
依托单位:
The structural dynamics of a glutamate transporter homologue
-
批准号:9322587
-
项目类别:
-
资助金额:$59.4万
-
财政年份:2014
-
负责人:Olga Boudker
-
依托单位:
The structural dynamics of a glutamate transporter homologue
-
批准号:8761326
-
项目类别:
-
资助金额:$61.14万
-
财政年份:2014
-
负责人:Olga Boudker
-
依托单位:
Isothermal Titration Calorimeter
-
批准号:8052085
-
项目类别:
-
资助金额:$26.62万
-
财政年份:2011
-
负责人:Olga Boudker
-
依托单位:
Conformational Ensemble of Glutamate Transporters: Structure and IonicModulation
-
批准号:9093846
-
项目类别:
-
资助金额:$37.08万
-
财政年份:2009
-
负责人:Olga Boudker
-
依托单位:
Conformational Ensemble of Glutamate Transporters: Structure and Ionic Modulatio
-
批准号:8077123
-
项目类别:
-
资助金额:$8.2万
-
财政年份:2009
-
负责人:Olga Boudker
-
依托单位:
Conformational Ensemble of Glutamate Transporters: Structure and IonicModulation
-
批准号:8811159
-
项目类别:
-
资助金额:$37.08万
-
财政年份:2009
-
负责人:Olga Boudker
-
依托单位:
Conformational Ensemble of Glutamate Transporters: Structure and Ionic Modulatio
-
批准号:8097421
-
项目类别:
-
资助金额:$36.23万
-
财政年份:2009
-
负责人:Olga Boudker
-
依托单位:
Conformational Ensemble of Glutamate Transporters: Structure and Ionic Modulatio
-
批准号:7736453
-
项目类别:
-
资助金额:$36.97万
-
财政年份:2009
-
负责人:Olga Boudker
-
依托单位:
Conformational Ensemble of Glutamate Transporters: Structure and Ionic Modulatio
-
批准号:8494099
-
项目类别:
-
资助金额:$34.96万
-
财政年份:2009
-
负责人:Olga Boudker
-
依托单位:
Conformational Ensemble of Glutamate Transporters: Structure and Ionic Modulatio
-
批准号:8281366
-
项目类别:
-
资助金额:$36.23万
-
财政年份:2009
-
负责人:Olga Boudker
-
依托单位:
Conformational Ensemble of Glutamate Transporters: Structure and IonicModulation
-
批准号:8697890
-
项目类别:
-
资助金额:$37.08万
-
财政年份:2009
-
负责人:Olga Boudker
-
依托单位:
国内基金
海外基金
基于ADK/Adenosine调控DNA甲基化探讨“利湿化瘀通络”法对2型糖尿病肾病足细胞裂孔膜损伤的干预机制研究
-
批准号:82074359
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:安晓飞
-
依托单位:
细胞外腺苷(Adenosine)作为干细胞旁分泌因子的生物学鉴定和功能分析
-
批准号:81570244
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2015
-
负责人:丁兆平
-
依托单位:
Adenosine诱导A1/A2AR稳态失衡启动慢性低灌注白质炎性损伤及其机制
-
批准号:81171113
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2011
-
负责人:黄文
-
依托单位: